How Usen was paid
$2.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Other | Total |
|---|---|---|---|---|---|
| Todd UsenChief Executive Officer | $500,000 | $330,000 | $1,631,865 | $38,608 | $2,500,473 |
| Deborah KasterChief Financial Officer | $251,902 | $101,097 | $483,038 | — | $836,037 |
| Hakon BergheimFormer Chief Operating Officer | $53,937 | — | — | $117,630 | $171,567 |
| John DahldorfFormer Chief Financial Officer | $104,640 | — | — | $49,037 | $153,677 |
What changed and why
- $2.5MTodd Usen received a total compensation of $2,500,473 for fiscal 2025.
- $836KDeborah Kaster was appointed as Chief Financial Officer and earned $836,037 in total compensation for 2025.
- Hakon Bergheim and John Dahldorf departed from their executive roles during early 2025.
- Stock options are valued using the Black-Scholes option pricing model.
- Annual bonuses for top executives were deferred until the company achieves specific 2026 financing goals.
Other Adagio Medical Holdings proxy statements
- 2025 proxy statement
Todd Usen paid $22,917.
Filed Nov 04, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.